Why SOPHiA GENETICS SA (SOPH) stock rose 5.3% on Thursday, November 12, 2026
SOPHiA GENETICS SA (SOPH) closed at $7.86, up 5.29% on Thursday, November 12, 2026, on volume of 732,309 shares (1.1× its 3-month average); market value about $700.0M, according to Nexqual market data (nexqual.com/moves/2026-11-12/SOPH).
What happened: primary sources
Events Nexqual found for SOPH on Thursday, November 12, 2026 or the trading day before (November 11, 2026), each linked to its primary source:
- Nov 12, 2026: Schedule 13D/A: Schindel Yair Chaim, aMoon Growth Fund Limited Partnership, 6.2% of shares, a 5%+ holder that may seek to influence the company source
Quoted from the filing: “On November 10, 2026, aMoon Edge sold an aggregate of 192,541 Ordinary Shares in a private block sale at a price of $7.70 per share for gross proceeds of approximately $1.48 million.”
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on SOPH
SOPH stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 12, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:49 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt